Hunan Nucien Pharmaceutical Co., Ltd. (SHA:688189)
China
· Delayed Price · Currency is CNY 7.99
-0.16 (-1.96%)
Mar 9, 2026, 4:00 PM EDT
SHA:688189 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Market Capitalization | 2,240 | 2,172 | 1,784 | 2,588 | 3,383 | 4,931 | Upgrade
|
| Market Cap Growth | 22.57% | 21.75% | -31.04% | -23.51% | -31.39% | -27.96% | Upgrade
|
| Enterprise Value | 1,895 | 1,827 | 1,435 | 2,370 | 3,402 | 4,800 | Upgrade
|
| Last Close Price | 8.22 | 7.97 | 6.54 | 9.43 | 12.33 | 17.97 | Upgrade
|
| Forward PE | - | 15.16 | 15.16 | 15.16 | 15.16 | 15.16 | Upgrade
|
| PS Ratio | 15.79 | 15.31 | 6.78 | 3.59 | 4.84 | 6.63 | Upgrade
|
| PB Ratio | 2.80 | 2.71 | 2.03 | 2.01 | 2.61 | 3.54 | Upgrade
|
| P/TBV Ratio | 3.05 | 2.96 | 2.25 | 2.22 | 2.90 | 4.04 | Upgrade
|
| P/FCF Ratio | - | - | - | 14.08 | - | - | Upgrade
|
| P/OCF Ratio | - | - | 1280.46 | 12.02 | - | - | Upgrade
|
| EV/Sales Ratio | 13.35 | 12.88 | 5.45 | 3.29 | 4.87 | 6.46 | Upgrade
|
| EV/EBITDA Ratio | - | - | - | 58.91 | - | - | Upgrade
|
| EV/EBIT Ratio | - | - | - | 546.78 | - | - | Upgrade
|
| EV/FCF Ratio | - | - | - | 12.90 | - | - | Upgrade
|
| Debt / Equity Ratio | 0.19 | 0.19 | 0.25 | 0.25 | 0.42 | 0.34 | Upgrade
|
| Debt / EBITDA Ratio | - | - | - | 7.81 | - | - | Upgrade
|
| Debt / FCF Ratio | - | - | - | 1.77 | - | - | Upgrade
|
| Net Debt / Equity Ratio | -0.35 | -0.35 | -0.31 | -0.26 | -0.13 | -0.18 | Upgrade
|
| Net Debt / EBITDA Ratio | 2.91 | 2.91 | 0.84 | -8.48 | 5.16 | 1.43 | Upgrade
|
| Net Debt / FCF Ratio | - | - | 4.75 | -1.86 | 0.84 | 1.45 | Upgrade
|
| Asset Turnover | - | - | 0.18 | 0.39 | 0.34 | 0.35 | Upgrade
|
| Inventory Turnover | - | - | 2.83 | 4.24 | 2.67 | 1.94 | Upgrade
|
| Quick Ratio | - | - | 2.05 | 2.88 | 2.25 | 2.27 | Upgrade
|
| Current Ratio | - | - | 2.29 | 2.97 | 2.31 | 2.39 | Upgrade
|
| Return on Equity (ROE) | -16.35% | -16.35% | -36.72% | -0.84% | -7.26% | -12.09% | Upgrade
|
| Return on Assets (ROA) | - | - | -15.29% | 0.15% | -2.44% | -6.38% | Upgrade
|
| Return on Invested Capital (ROIC) | -25.44% | -23.49% | -46.39% | 0.42% | -7.03% | -20.19% | Upgrade
|
| Return on Capital Employed (ROCE) | - | - | -40.80% | 0.30% | -6.10% | -14.80% | Upgrade
|
| Earnings Yield | -6.13% | -6.32% | -20.00% | -0.42% | -2.33% | -3.28% | Upgrade
|
| FCF Yield | - | - | -3.20% | 7.10% | -5.94% | -3.58% | Upgrade
|
| Buyback Yield / Dilution | 0.08% | 0.08% | 0.03% | -0.03% | 0.01% | -6.66% | Upgrade
|
| Total Shareholder Return | 0.08% | 0.08% | 0.03% | -0.03% | 0.01% | -6.66% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.